Oncology is evolving quickly
Treatment patterns are changing in community care. Dispensing dynamics continue to shape how therapies move through the market. For biopharma leaders, these shifts can influence how strategy takes shape across access, commercialization, and performance.
Explore two thought leadership pieces that examine important changes in oncology treatment adoption and specialty network design, and what those changes may mean for decision-makers navigating a complex market.
Explore two thought leadership pieces that examine important changes in oncology treatment adoption and specialty network design, and what those changes may mean for decision-makers navigating a complex market.
Where the market comes into view
Maximizing prescription capture rates at medically integrated dispensing sites
This perspective examines how limited specialty network models may influence prescription capture at medically integrated dispensing sites within private oncology practices. It compares network structures and highlights findings that suggest more selective models may be associated with stronger internal capture performance.
Transforming bladder cancer treatment: The rise of immunotherapy in community oncology practices
This perspective examines how community oncology practices have increasingly adopted immunotherapy as first-line treatment for bladder cancer. It explores the growing use of enfortumab vedotin-ejfv in combination with pembrolizumab following trial results and Food and Drug Administration approvals, along with shifts in regimen share over time.
Why these shifts matter
In oncology, strategy is shaped by more than one signal. Treatment adoption, market access dynamics, and dispensing pathways can all influence how biopharma teams assess opportunity and plan for what comes next. Together, these perspectives offer a broader view of the forces changing the market.
Understand how treatment patterns are changing in community oncology.
See how dispensing and network dynamics may influence performance.
Gain perspective on the oncology signals shaping biopharma strategy.
Connect with a team that understands oncology
Thought leadership can help reveal what is changing in the market.
We help upstream biopharma teams go further through analytics and insights that support planning, prioritization, and decision-making in a complex oncology environment. Connect with our team to see how we can help you translate market signals into strategic direction.